跳至主要内容
临床试验/CTRI/2024/04/066403
CTRI/2024/04/066403招募中Unknown

Active surveillance of the safety of Gadolinium-based contrast agent(s) in India - NI

Bayer Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. GBCA-naïve male or female patients of at least 18 years of age
  • 2. willing to participate in the active surveillance and agree to be contacted by phone after 6 (±2)
  • weeks after the MR scan for brief interviews

排除标准

  • There is no specific exclusion criteria.

研究者

相似试验

To conduct survey of safety of Gadolinium-based... | 临床试验